Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 laser-assisted topical articaine versus topical EMLA for local skin anesthesia
NL-OMON42101Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of articaine, lidocaine + prilocaine and epinephrine in acne scar and residual scarring (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Pain intensity after laser treatment. Started Jun 2015; status: active, not recruiting.
02
Drugs
articainelidocaine + prilocaineepinephrine
03
Conditions
acne scarresidual scarring
Beyond the preview
Go deeper on NL-OMON42101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42101.